Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteus Infections”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableStudy completedNCT00363220
What this trial is testing

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

Who this might be right for
InfectionE Coli InfectionsKlebsiella Infections+1 more
University of Pittsburgh 100
Not applicableLooking for participantsNCT06010563
What this trial is testing

VenusP-Valve Pivotal Study (PROTEUS STUDY)

Who this might be right for
Pulmonary Regurgitation
Venus MedTech (HangZhou) Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980872
What this trial is testing

The Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Merck Sharp & Dohme LLC 60
Not applicableStudy completedNCT04146922
What this trial is testing

Switch to Oral Antibiotics in Gram-negative Bacteremia

Who this might be right for
Escherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter Bacteraemia+3 more
Hamad Medical Corporation 176
Testing effectiveness (Phase 2)Ended earlyNCT03094832
What this trial is testing

Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002)

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 50
Not applicableStudy completedNCT02827630
What this trial is testing

Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Hypercholesterolemia
Proteus Digital Health, Inc. 118
Not applicableStudy completedNCT01369953
What this trial is testing

Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants

Who this might be right for
Coronary Artery DiseaseProteus SyndromeCoffin - Sins Syndrome+2 more
National Human Genome Research Institute (NHGRI) 30
Not applicableWithdrawnNCT01503008
What this trial is testing

Proteus Sustained Behavior Change Study

Who this might be right for
Type 2 Diabetes Mellitus
Proteus Digital Health, Inc.
Early research (Phase 1)Study completedNCT02594215
What this trial is testing

Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome

Who this might be right for
Proteus Syndrome
National Human Genome Research Institute (NHGRI) 6
Post-approval studies (Phase 4)Study completedNCT01960257
What this trial is testing

Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis

Who this might be right for
Tuberculosis
University of California, San Diego 92
Not applicableActive Not RecruitingNCT07153094
What this trial is testing

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

Who this might be right for
Solid Tumor, Adult
Ion Beam Applications 47
Not applicableLooking for participantsNCT00001403
What this trial is testing

Study of Proteus Syndrome and Related Congenital Disorders

Who this might be right for
Proteus SyndromePIK3CA Related Overgrowth Spectrum
National Human Genome Research Institute (NHGRI) 1,500
Not applicableNo Longer AvailableNCT03317366
What this trial is testing

Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

Who this might be right for
Proteus SyndromePIK3CA-Related Overgrowth Spectrum (PROS)Growth Disorders
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Not applicableUnknownNCT05028179
What this trial is testing

PROTEUS: Evaluating the Use of Artificial Intelligence to Support Stress Echocardiography Testing for Heart Disease

Who this might be right for
Coronary Heart Disease
Ultromics Ltd 2,338
Not applicableStudy completedNCT06542965
What this trial is testing

Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis

Who this might be right for
Proteus Mirabilis InfectionBacteremiaCarbapenem Resistant Bacterial Infection
Dokuz Eylul University 67
Post-approval studies (Phase 4)UnknownNCT02800655
What this trial is testing

Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy

Who this might be right for
HIV
University of California, San Diego 100
Large-scale testing (Phase 3)Study completedNCT01941329
What this trial is testing

Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.

Who this might be right for
High Risk Proliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 94
Not applicableActive Not RecruitingNCT07152353
What this trial is testing

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

Who this might be right for
Solid Tumor, Adult
Ion Beam Applications 47
Not applicableActive Not RecruitingNCT07137195
What this trial is testing

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

Who this might be right for
Solid Tumor, Adult
Ion Beam Applications 47
Testing effectiveness (Phase 2)Looking for participantsNCT04316546
What this trial is testing

MK-7075 (Miransertib) in Proteus Syndrome

Who this might be right for
Proteus Syndrome
National Human Genome Research Institute (NHGRI) 45
Load More Results